{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T08:58:31Z","timestamp":1777885111236,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T00:00:00Z","timestamp":1489795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T00:00:00Z","timestamp":1489795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.","award":["91119"],"award-info":[{"award-number":["91119"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00705-017-3315-3","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T12:19:46Z","timestamp":1489839586000},"page":"1951-1962","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Expression and characterization of codon-optimized Crimean-Congo hemorrhagic fever virus Gn glycoprotein in insect cells"],"prefix":"10.1007","volume":"162","author":[{"given":"Mehdi","family":"Rahpeyma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Samarbaf-Zadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoochehr","family":"Makvandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ata A.","family":"Ghadiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart D.","family":"Dowall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Fotouhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,18]]},"reference":[{"key":"3315_CR1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1128\/JVI.80.1.514-525.2006","volume":"80","author":"A Sanchez","year":"2006","unstructured":"Sanchez A, Vincent M, Erickson B, Nichol S (2006) Crimean-Congo hemorrhagic fever virus glycoprotein precursor is cleaved by Furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein. J Virol 80:514\u2013525","journal-title":"J Virol"},{"key":"3315_CR2","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1086\/500836","volume":"193","author":"O Ergonul","year":"2006","unstructured":"Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B (2006) Evaluation of Serum Levels of Interleukin (IL)\u20136, IL-10, and Tumor Necrosis Factor\u2013\u03b1 in Patients with Crimean-Congo Hemorrhagic Fever. J Infect Dis 193:941\u2013944","journal-title":"J Infect Dis"},{"key":"3315_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0972-9062.117470","volume":"50","author":"A Dash","year":"2013","unstructured":"Dash A, Bhatia R, Sunyoto T, Mourya D (2013) Emerging and re-emerging arboviral diseases in Southeast Asia. J Vector Borne Dis 50:77\u201384","journal-title":"J Vector Borne Dis"},{"key":"3315_CR4","doi-asserted-by":"crossref","unstructured":"Gray J, Dautel H, Estrada-Pe\u00f1a A, Kahl O, Lindgren E (2009) Effects of climate change on ticks and tick-borne diseases in Europe. Interdiscip Persp Infect Dis","DOI":"10.1155\/2009\/593232"},{"key":"3315_CR5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1089\/vbz.2011.0770","volume":"12","author":"B Atkinson","year":"2012","unstructured":"Atkinson B, Chamberlain J, Logue CH, Cook N, Bruce C et al (2012) Development of a real-time RT-PCR assay for the detection of Crimean-Congo hemorrhagic fever virus. Vector-Borne Zoonotic Dis 12:786\u2013793","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"3315_CR6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7883\/yoken.JJID.2006.326","volume":"59","author":"S Izadi","year":"2006","unstructured":"Izadi S, Holakouie-Naieni K, Majdzadeh SR, Chinikar S, Nadim A et al (2006) Seroprevalence of Crimean- Congo hemorrhagic fever in Sistan-va-Baluchestan province of Iran. Jpn J Infect Dis 59:326","journal-title":"Jpn J Infect Dis"},{"key":"3315_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1743-422X-5-7","volume":"5","author":"D Duh","year":"2008","unstructured":"Duh D, Nichol S, Khristova M, Saksida A, Hafner-Bratkovic I et al (2008) The complete genome sequence of a Crimean-Congo Hemorrhagic Fever virus isolated from an endemic region in Kosovo. Virol J 5:7","journal-title":"Virol J"},{"key":"3315_CR8","doi-asserted-by":"crossref","unstructured":"Bergeron E, Vincent M, Nichol S (2007) Crimean Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1\/S1P is critical for virus infectivity. J Virol","DOI":"10.1128\/JVI.01647-07"},{"key":"3315_CR9","doi-asserted-by":"publisher","first-page":"e1160","DOI":"10.1016\/j.ijid.2013.07.015","volume":"17","author":"M Sargianou","year":"2013","unstructured":"Sargianou M, Panos G, Tsatsaris A, Gogos C, Papa A (2013) Crimean-Congo hemorrhagic fever: seroprevalence and risk factors among humans in Achaia, western Greece. Int J Infect Dis 17:e1160\u2013e1165","journal-title":"Int J Infect Dis"},{"key":"3315_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.antiviral.2013.07.007","volume":"100","author":"M Keshtkar-Jahromi","year":"2013","unstructured":"Keshtkar-Jahromi M, Sajadi MM, Ansari H, Mardani M, Holakouie-Naieni K (2013) Crimean-Congo hemorrhagic fever in Iran. Antiviral Res 100:20\u201328","journal-title":"Antiviral Res"},{"key":"3315_CR11","first-page":"151","volume":"12","author":"B Sharifi-Mood","year":"2009","unstructured":"Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, Akrami E (2009) The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. Arch Iran Med 12:151\u2013153","journal-title":"Arch Iran Med"},{"key":"3315_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jcv.2014.08.029","volume":"64","author":"A Papa","year":"2014","unstructured":"Papa A, Mirazimi A, Koksal I, Estrada-Pena A, Feldmann H (2014) Recent advances in research on Crimean-Congo hemorrhagic fever. J Clin Virol 64:137\u2013143","journal-title":"J Clin Virol"},{"key":"3315_CR13","doi-asserted-by":"publisher","first-page":"3327","DOI":"10.1099\/vir.0.81175-0","volume":"86","author":"AA Ahmed","year":"2005","unstructured":"Ahmed AA, McFalls JM, Hoffmann C, Filone CM, Stewart SM et al (2005) Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo hemorrhagic fever virus. J Gene Virol 86:3327\u20133336","journal-title":"J Gene Virol"},{"key":"3315_CR14","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","volume":"79","author":"A Bertolotti-Ciarlet","year":"2005","unstructured":"Bertolotti-Ciarlet A, Smith J, Strecker K, Paragas J, Altamura LA et al (2005) Cellular localization and antigenic characterization of Crimean-Congo hemorrhagic fever virus glycoproteins. J Virol 79:6152\u20136161","journal-title":"J Virol"},{"key":"3315_CR15","doi-asserted-by":"publisher","first-page":"7263","DOI":"10.1128\/JVI.76.14.7263-7275.2002","volume":"76","author":"AJ Sanchez","year":"2002","unstructured":"Sanchez AJ, Vincent MJ, Nichol ST (2002) Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J Virol 76:7263\u20137275","journal-title":"J Virol"},{"key":"3315_CR16","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1128\/JVI.02730-06","volume":"81","author":"LA Altamura","year":"2007","unstructured":"Altamura LA, Bertolotti-Ciarlet A, Teigler J, Paragas J, Schmaljohn CS et al (2007) Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein. J Virol 81:6632\u20136642","journal-title":"J Virol"},{"key":"3315_CR17","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3390\/v6041801","volume":"6","author":"N Cifuentes-Mu\u00f1oz","year":"2014","unstructured":"Cifuentes-Mu\u00f1oz N, Salazar-Quiroz N, Tischler ND (2014) Hantavirus Gn and Gc envelope glycoproteins: key structural units for virus cell entry and virus assembly. Viruses 6:1801\u20131822","journal-title":"Viruses"},{"key":"3315_CR18","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1099\/vir.0.013540-0","volume":"90","author":"X Shi","year":"2009","unstructured":"Shi X, Goli J, Clark G, Brauburger K, Elliott RM (2009) Functional analysis of the Bunyamwera orthobunyavirus Gc glycoprotein. J Gene Virol 90:2483\u20132492","journal-title":"J Gene Virol"},{"key":"3315_CR19","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jip.2011.05.002","volume":"107","author":"SW Metz","year":"2011","unstructured":"Metz SW, Pijlman GP (2011) Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system. J Invertebr Pathol 107:S16\u2013S30","journal-title":"J Invertebr Pathol"},{"key":"3315_CR20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1089\/vbz.2014.1650","volume":"14","author":"B Faburay","year":"2014","unstructured":"Faburay B, Lebedev M, McVey DS, Wilson W, Morozov I et al (2014) A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep. Vector-Borne Zoonotic Dis 14:746\u2013756","journal-title":"Vector-Borne Zoonotic Dis"},{"key":"3315_CR21","doi-asserted-by":"publisher","first-page":"008","DOI":"10.4172\/2157-2526.S1-008","volume":"1","author":"RB Mandell","year":"2011","unstructured":"Mandell RB, Flick R (2011) Virus-like particle-based vaccines for Rift Valley fever virus. J Bioterr Biodef S1:008. doi:10.4172\/2157-2526.S1-008","journal-title":"J Bioterr Biodef S"},{"key":"3315_CR22","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1289\/ehp.95103756","volume":"103","author":"RM Patterson","year":"1995","unstructured":"Patterson RM, Selkirk JK, Merrick BA (1995) Baculovirus and insect cell gene expression: review of baculovirus biotechnology. Environ Health Perspect 103:756\u2013759","journal-title":"Environ Health Perspect"},{"key":"3315_CR23","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2174\/156652310791321288","volume":"10","author":"MG Aucoin","year":"2010","unstructured":"Aucoin MG, Mena JA, Kamen AA (2010) Bioprocessing of baculovirus vectors: a review. Curr Gene Ther 10:174\u2013186","journal-title":"Curr Gene Ther"},{"key":"3315_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/187220809787172669","volume":"3","author":"RB Hitchman","year":"2009","unstructured":"Hitchman RB, Possee RD, King LA (2009) Baculovirus expression systems for recombinant protein production in insect cells. Recent Pat Biotechnol 3:46\u201354","journal-title":"Recent Pat Biotechnol"},{"key":"3315_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1745-7254.2005.00078.x","volume":"26","author":"Hu Y-c","year":"2005","unstructured":"Y-c Hu (2005) Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 26:405\u2013416","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"3315_CR26","doi-asserted-by":"publisher","first-page":"e25502","DOI":"10.5812\/jjm.25502","volume":"8","author":"M Rahpeyma","year":"2015","unstructured":"Rahpeyma M, Fotouhi F, Makvandi M, Ghadiri A, Samarbaf-Zadeh A (2015) Crimean-Congo hemorrhagic fever virus Gn bioinformatic analysis and construction of a recombinant bacmid in order to express Gn by baculovirus expression system. Jundishapur J Microbiol 8(11):e25502. doi:10.5812\/jjm.25502","journal-title":"Jundishapur J Microbiol"},{"key":"3315_CR27","doi-asserted-by":"crossref","unstructured":"Sambrook J, Russell DW (2006) Preparation and transformation of competent E. coli using calcium chloride. Cold Spring Harbor Protocols 2006: pdb. prot3932","DOI":"10.1101\/pdb.prot3932"},{"key":"3315_CR28","doi-asserted-by":"crossref","unstructured":"Yousefi A, Fotouhi F, Hosseinzadeh S, Kheiri M, Farahmand B et al (2012) Expression of antigenic determinants of the haemagglutinin large subunit of novel influenza virus in insect cells. Folia Biologica 58:151","DOI":"10.14712\/fb2012058040151"},{"key":"3315_CR29","doi-asserted-by":"publisher","first-page":"8640","DOI":"10.1128\/JVI.77.16.8640-8649.2003","volume":"77","author":"MJ Vincent","year":"2003","unstructured":"Vincent MJ, Sanchez AJ, Erickson BR, Basak A, Chretien M et al (2003) Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1. J Virol 77:8640\u20138649","journal-title":"J Virol"},{"key":"3315_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.antiviral.2011.02.010","volume":"90","author":"M Keshtkar-Jahromi","year":"2011","unstructured":"Keshtkar-Jahromi M, Kuhn JH, Christova I, Bradfute SB, Jahrling PB et al (2011) Crimean-Congo hemorrhagic fever: Current and future prospects of vaccines and therapies. Antiviral Res 90:85\u201392","journal-title":"Antiviral Res"},{"key":"3315_CR31","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4269\/ajtmh.2012.12-0337","volume":"88","author":"H Naderi","year":"2013","unstructured":"Naderi H, Sheybani F, Bojdi A, Khosravi N, Mostafavi I (2013) Fatal nosocomial spread of Crimean-Congo hemorrhagic fever with very short incubation period. Am J Trop Med Hygiene 88:469\u2013471","journal-title":"Am J Trop Med Hygiene"},{"key":"3315_CR32","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","volume":"287","author":"L Borio","year":"2002","unstructured":"Borio L, Inglesby T, Peters CJ et al (2002) Hemorrhagic fever viruses as biological weapons: Medical and public health management. JAMA 287:2391\u20132405","journal-title":"JAMA"},{"key":"3315_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.virol.2009.06.010","volume":"390","author":"A-M Connolly-Andersen","year":"2009","unstructured":"Connolly-Andersen A-M, Douagi I, Kraus AA, Mirazimi A (2009) Crimean Congo hemorrhagic fever virus infects human monocyte-derived dendritic cells. Virology 390:157\u2013162","journal-title":"Virology"},{"key":"3315_CR34","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/jmv.20270","volume":"75","author":"M Saijo","year":"2005","unstructured":"Saijo M, Tang Q, Shimayi B, Han L, Zhang Y et al (2005) Recombinant nucleoprotein-based serological diagnosis of Crimean-Congo hemorrhagic fever virus infections. J Med Virol 75:295\u2013299","journal-title":"J Med Virol"},{"key":"3315_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/jmv.20530","volume":"78","author":"I Andersson","year":"2006","unstructured":"Andersson I, Lundkvist \u00c5, Haller O, Mirazimi A (2006) Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J Med Virol 78:216\u2013222","journal-title":"J Med Virol"},{"key":"3315_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tig.2007.12.006","volume":"24","author":"M Pop","year":"2008","unstructured":"Pop M, Salzberg SL (2008) Bioinformatics challenges of new sequencing technology. Trends Genet 24:142\u2013149","journal-title":"Trends Genet"},{"key":"3315_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0968-0004(00)01757-6","volume":"26","author":"JP Muyrers","year":"2001","unstructured":"Muyrers JP, Zhang Y, Stewart AF (2001) Techniques: recombinogenic engineering\u2013new options for cloning and manipulating DNA. Trends Biochem Sci 26:325\u2013331","journal-title":"Trends Biochem Sci"},{"key":"3315_CR38","doi-asserted-by":"crossref","unstructured":"Dreshaj S, Ahmeti S, Ramadani N, Dreshaj G, Humolli I et al (2016) Current situation of Crimean-Congo hemorrhagic fever in Southeastern Europe and neighboring countries: a public health risk for the European Union? Travel Med Infect Dis 14:81\u201391","DOI":"10.1016\/j.tmaid.2016.03.012"},{"key":"3315_CR39","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7883\/yoken.64.439","volume":"64","author":"A Kubar","year":"2011","unstructured":"Kubar A, Haciomeroglu M, Ozkul A, Bagriacik U, Akinci E et al (2011) Prompt administration of Crimean-Congo hemorrhagic fever (CCHF) virus hyperimmunoglobulin in patients diagnosed with CCHF and viral load monitorization by reverse transcriptase-PCR. Jpn J Infect Dis 64:439\u2013443","journal-title":"Jpn J Infect Dis"},{"key":"3315_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.coviro.2012.03.001","volume":"2","author":"O Ergonul","year":"2012","unstructured":"Ergonul O (2012) Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol 2:215\u2013220","journal-title":"Curr Opin Virol"},{"key":"3315_CR41","doi-asserted-by":"crossref","unstructured":"Zhu Z, Dimitrov AS, Chakraborti S, Dimitrova D, Xiao X et al (2006) Development of human monoclonal antibodies against diseases caused by emerging and biodefense-related viruses","DOI":"10.1586\/14787210.4.1.57"},{"key":"3315_CR42","doi-asserted-by":"publisher","first-page":"e91516","DOI":"10.1371\/journal.pone.0091516","volume":"9","author":"KR Buttigieg","year":"2014","unstructured":"Buttigieg KR, Dowall SD, Findlay-Wilson S, Miloszewska A, Rayner E et al (2014) A novel vaccine against Crimean-Congo haemorrhagic fever protects 100% of animals against lethal challenge in a mouse model. PloS One 9:e91516","journal-title":"PloS One"},{"key":"3315_CR43","doi-asserted-by":"crossref","unstructured":"Dowall S, Buttigieg K, Findlay-Wilson S, Rayner E, Pearson G et al (2015) A Crimean-Congo Haemorrhagic Fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease. Human Vaccin Immunotherap","DOI":"10.1080\/21645515.2015.1078045"},{"key":"3315_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1385\/MB:28:3:241","volume":"28","author":"SA Brooks","year":"2004","unstructured":"Brooks SA (2004) Appropriate glycosylation of recombinant proteins for human use. Mol Biotechn 28:241\u2013255","journal-title":"Mol Biotechn"},{"key":"3315_CR45","first-page":"1121","volume":"80","author":"M Rai","year":"2001","unstructured":"Rai M, Padh H (2001) Expression systems for production of heterologous proteins. Curr Sci Bangal 80:1121\u20131128","journal-title":"Curr Sci Bangal"},{"key":"3315_CR46","doi-asserted-by":"publisher","first-page":"8122","DOI":"10.1073\/pnas.83.21.8122","volume":"83","author":"TR Fuerst","year":"1986","unstructured":"Fuerst TR, Niles EG, Studier FW, Moss B (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proceed Nat Acad Sci 83:8122\u20138126","journal-title":"Proceed Nat Acad Sci"},{"key":"3315_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/yea.1208","volume":"22","author":"S Macauley-Patrick","year":"2005","unstructured":"Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM (2005) Heterologous protein production using the Pichia pastoris expression system. Yeast 22:249\u2013270","journal-title":"Yeast"},{"key":"3315_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0167-7799(97)01155-4","volume":"16","author":"G Hannig","year":"1998","unstructured":"Hannig G, Makrides SC (1998) Strategies for optimizing heterologous protein expression in Escherichia coli. Trends Biotechn 16:54\u201360","journal-title":"Trends Biotechn"},{"key":"3315_CR49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/jvi.64.1.37-50.1990","volume":"64","author":"J Vialard","year":"1990","unstructured":"Vialard J, Lalumiere M, Vernet T, Briedis D, Alkhatib G et al (1990) Synthesis of the membrane fusion and hemagglutinin proteins of measles virus, using a novel baculovirus vector containing the beta- galactosidase gene. J Virol 64:37\u201350","journal-title":"J Virol"},{"key":"3315_CR50","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.4049\/jimmunol.171.3.1133","volume":"171","author":"T Abe","year":"2003","unstructured":"Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y et al (2003) Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 171:1133\u20131139","journal-title":"J Immunol"},{"key":"3315_CR51","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1073\/pnas.88.11.4646","volume":"88","author":"S Kajigaya","year":"1991","unstructured":"Kajigaya S, FuJII H, Field A, Anderson S, Rosenfeld S et al (1991) Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proceed Nat Acad Sci 88:4646\u20134650","journal-title":"Proceed Nat Acad Sci"},{"key":"3315_CR52","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1574-695X.2008.00438.x","volume":"54","author":"F Fotouhi","year":"2008","unstructured":"Fotouhi F, Soleimanjahi H, Roostaee MH, Behzadian F (2008) Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting. FEMS Immunol Med Microbiol 54:18\u201326","journal-title":"FEMS Immunol Med Microbiol"},{"key":"3315_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pep.2005.11.024","volume":"48","author":"B Qian","year":"2006","unstructured":"Qian B, Shen H, Xiong J, Chen L, Zhang L et al (2006) Expression and purification of the synthetic preS1 gene of Hepatitis B Virus with preferred Escherichia coli codon preference. Protein expression and purification 48:74\u201380","journal-title":"Protein expression and purification"},{"key":"3315_CR54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00253-005-0287-0","volume":"72","author":"Z Xu","year":"2006","unstructured":"Xu Z, Zhong Z, Huang L, Peng L, Wang F et al (2006) High-level production of bioactive human beta- defensin-4 in Escherichia coli by soluble fusion expression. Appl Microbiol Biotechnol 72:471\u2013479","journal-title":"Appl Microbiol Biotechnol"},{"key":"3315_CR55","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/0929866043406760","volume":"11","author":"L Peng","year":"2004","unstructured":"Peng L, Xu Z, Fang X, Wang F, Yang S et al (2004) Preferential codons enhancing the expression level of human beta-defensin-2 in recombinant Escherichia coli. Protein Pept Lett 11:339\u2013344","journal-title":"Protein Pept Lett"},{"key":"3315_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12896-015-0177-1","volume":"15","author":"X Lu","year":"2015","unstructured":"Lu X, Wang J, Jin X, Zhu J (2015) High-level expression of a novel liver-targeting fusion interferon with preferred Escherichia coli codon preference and its anti-hepatitis B virus activity in vivo. BMC Biotechnol 15:1","journal-title":"BMC Biotechnol"},{"key":"3315_CR57","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1001\/jama.297.14.1577","volume":"297","author":"JJ Treanor","year":"2007","unstructured":"Treanor JJ, Schiff GM, Hayden FG, Brady RC, Hay CM et al (2007) Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA 297:1577\u20131582","journal-title":"JAMA"},{"key":"3315_CR58","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0065-3527(06)68006-8","volume":"68","author":"MM Van Oers","year":"2006","unstructured":"Van Oers MM (2006) Vaccines for viral and parasitic diseases produced with baculovirus vectors. Adv Virus Res 68:193\u2013253","journal-title":"Adv Virus Res"},{"key":"3315_CR59","first-page":"1086","volume":"17","author":"A Saksida","year":"2010","unstructured":"Saksida A, Duh D, Wraber B, Dedushaj I, Ahmeti S et al (2010) Interacting roles of immune mechanisms and viral load in the pathogenesis of Crimean-Congo hemorrhagic fever. ClinVacc Immunol 17:1086\u20131093","journal-title":"ClinVacc Immunol"},{"key":"3315_CR60","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0065-2776(07)96002-2","volume":"96","author":"JR Schoenborn","year":"2007","unstructured":"Schoenborn JR, Wilson CB (2007) Regulation of Interferon-\u03b3 During Innate and Adaptive Immune Responses. Adv Immunol: Academic Press 96:41\u2013101","journal-title":"Adv Immunol: Academic Press"},{"key":"3315_CR61","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S1359-6101(03)00043-1","volume":"14","author":"WT Watford","year":"2003","unstructured":"Watford WT, Moriguchi M, Morinobu A, O\u2019Shea JJ (2003) The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 14:361\u2013368","journal-title":"Cytokine Growth Factor Rev"},{"key":"3315_CR62","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.chom.2007.09.014","volume":"2","author":"N Frias-Staheli","year":"2007","unstructured":"Frias-Staheli N, Giannakopoulos NV, Kikkert M, Taylor SL, Bridgen A et al (2007) Ovarian tumor domain-containing viral proteases evade ubiquitin-and ISG15-dependent innate immune responses. Cell Host Microbe 2:404\u2013416","journal-title":"Cell Host Microbe"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-017-3315-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3315-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-017-3315-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:06:31Z","timestamp":1744149991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-017-3315-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,18]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["3315"],"URL":"https:\/\/doi.org\/10.1007\/s00705-017-3315-3","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,18]]},"assertion":[{"value":"19 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was funded by Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran (PhD Grant No. 91119).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare that they have no conflict of interest","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal experiments described in this paper were conducted according to NIH guidelines for the care and use of laboratory animals and were approved by the ethics committee of Ahvaz Jundishapour University of Medical Sciences (Approval No. 2015-4-13). All procedures performed in studies involving human samples were approved by the ethics committee of Ahvaz Jundishapour University of Medical Sciences (Approval No. 2015-4-13) and were in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Studies using human samples were retrospective, and therefore, informed consent from the patients for their use in this study was not obtained.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}